跳至主要内容
临床试验/IRCT2013120215530N2
IRCT2013120215530N2已完成2 期

The role of ganciclovir in the prevention of Post-transplant lymph proliferative disease in children underwent liver transplantation

Vice Chancellor for research,Shiraz University of Medical Sciences0 个研究点目标入组 203 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
203

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 18 years(—)
性别
All

入选标准

  • age less than 18 years; performing a liver transplant
  • Exclusion criteria: transplant before July 88 and after March 90; die within the first week after transplantation due to postoperative complications

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research,Shiraz University of Medical Sciences

相似试验

role of ganciclovir in the prevention of... | 临床试验